Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-05

FDA Approved: PHENTERMINE HYDROCHLORIDE — Supplemental Application (TAGI Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for phentermine hydrochloride from TAGI Pharma, Inc., confirming the generic status of this obesity treatment under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phentermine hydrochloride (Phentermine hydrochloride)

Snippet

SUPPL AP for PHENTERMINE HYDROCHLORIDE (PHENTERMINE HYDROCHLORIDE)